Resources
Proteomics Databases
Metabolomics Databases

-
• Cross-Linking Mass Spectrometry (XL-MS) for Protein Interaction Mapping
Discover how cross-linking mass spectrometry identifies spatially linked residues and helps researchers investigate protein interaction interfaces and complex architecture.
-
• Beads, Eluate or Gel Band? How to Submit IP and Pull-Down Samples for Mass Spectrometry
Choose beads, eluate, or gel band for IP and Pull-Down LC-MS/MS submission by recovery, residual reagents, controls, and the intended identification question.
-
• Co-IP vs Pull-Down vs Proximity Labeling: Choosing a Protein Interaction Method
Compare Co-IP, Pull-Down, and proximity labeling by material, context, and evidence type. Choose a starting route from the research claim.
-
• Co-IP-MS Experimental Design: IgG and Empty-Vector Controls, Replicates and Grouping
Plan Co-IP-MS studies with IgG, empty-vector, tag-only, and beads-only controls. Explore biological replicate planning, group comparisons, and bait recovery.
-
• Serum Proteomics: Sample Preparation,Workflow Analysis, and Research Applications
Serum is the liquid fraction obtained after whole blood has clotted and the clot has been separated. It contains albumin, immunoglobulins, complement proteins, and many other circulating proteins. Serum proteomics is the systematic identification and relative quantification of proteins in serum, commonly using liquid chromatography–tandem mass spectrometry (LC-MS/MS).
-
• Serum Proteomics Applications in Disease and Drug Response Research
Serum proteomics can be applied when a study asks whether circulating protein profiles differ with disease status, disease severity, or treatment exposure. Typical comparisons include disease versus control samples, different disease states, and treated versus untreated or pre- versus post-treatment samples.
-
• Serum Proteomics for Biomarker Discovery: From Differential Proteins to Candidate Selection
Serum proteomics biomarker discovery often begins with a list of differential proteins, but that list is not yet a biomarker panel. Candidate selection asks which protein changes are sufficiently consistent, biologically relevant, and analytically feasible to justify further verification.
-
• How to Interpret Serum Proteomics Results and Quality Metrics
Serum proteomics reports contain several layers of information, from protein identification and relative quantification to sample-level quality metrics, differential proteins, and functional analysis. These results should be read in sequence rather than interpreted independently.
-
• Comparative Serum Proteomics: Study Design for Differential Protein Analysis
Comparative serum proteomics examines protein abundance differences between defined biological groups or sampling time points. The value of differential protein analysis depends on whether those comparisons are supported by an appropriate study design.
-
• Serum vs. Plasma Proteomics: Key Differences and Sample Selection
Both serum and plasma can be used for LC-MS/MS-based proteomics, but they are not interchangeable sample matrices. Differences in coagulation, anticoagulant use, and sample formation alter the abundance of specific protein groups, which can lead to differences in protein identification and relative quantification.
How to order?
